Copyright
©The Author(s) 2025.
World J Methodol. Dec 20, 2025; 15(4): 105287
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.105287
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.105287
Table 3 Response to attitude-based questions, n (%)
Nursing students | MBBS students | Resident doctors | Consultants (n = 40) | Nursing staff (n = 161) | Paramedical staff (n = 10) | P value | |
Q1. Glaucoma and cataracts are the same. | |||||||
Yes | 3 (6) | 0 | 1 (2.5) | 0 | 5 (3.1) | 0 | < 0.011 |
No | 46 (92) | 104 (85.2) | 37 (92.5) | 40 (100) | 155 (96.2) | 9 (90) | |
Do not know | 1 (2) | 18 (14.8) | 2 (5) | 0 | 1 (0.6) | 1 (10) | |
Q2. Glaucoma occurs without symptoms. | |||||||
Yes | 8 (16) | 20 (16.4) | 25 (62.5) | 26 (65) | 45 (27.9) | 1 (10) | < 0.011 |
No | 38 (76) | 48 (39.3) | 13 (32.5) | 14 (35) | 113 (70.1) | 7 (70) | |
Do not know | 4 (8) | 54 (44.3) | 2 (5) | 0 | 3 (1.8) | 2 (20) | |
Q3. Risk factors for glaucoma. | |||||||
High BP | 18 (36) | 53 (42.5) | 20 (50) | 10 (25) | 87 (54) | 1 (10) | < 0.011 |
Old age | 26 (52) | 31 (24.7) | 18 (45) | 9 (22.5) | 82 (50.9) | 4 (40) | |
Family history | 13 (26) | 25 (21.5) | 25 (62.5) | 8 (20) | 40 (24.8) | 4 (40) | |
Steroid use | 7 (14) | 6 (4.7) | 21 (52.5) | 21 (52.5) | 23 (14.2) | 0 | |
Do not know | 0 | 18 (14.8) | 3 (7.5) | 4 (10) | 4 (2.4) | 1 (10) | |
Q4. Early blindness from glaucoma is preventable. | |||||||
Yes | 38 (76) | 65 (53.3) | 37 (92.5) | 40 (100) | 140 (86.9) | 9 (90) | < 0.011 |
No | 8 (16) | 10 (8.2) | 0 | 0 | 10 (6.2) | 1 (10) | |
Do not know | 4 (8) | 47 (36.9) | 3 (7.5) | 0 | 11 (6.8) | 0 | |
Q5. Peripheral vision loss occurs in glaucoma. | |||||||
Yes | 35 (70) | 67 (54.9) | 32 (80) | 27 (67.5) | 136 (84.4) | 7 (70) | < 0.011 |
No | 8 (16) | 6 (4.9) | 3 (7.5) | 2 (5) | 10 (6.2) | 3 (30) | |
Do not know | 7 (14) | 49 (40.2) | 5 (12.5) | 11 (27.5) | 15 (9.3) | 0 | |
Q6. What happens to eye pressure in glaucoma? | |||||||
Increases | 44 (88) | 98 (80.3) | 37 (92.5) | 40 (100) | 158 (98.1) | 8 (80) | < 0.011 |
Decreases | 2 (4) | 4 (3.3) | 1 (2.5) | 0 | 0 | 0 | |
Do not know | 4 (8) | 20 (16.3) | 2 (5) | 0 | 3 (1.8) | 2 (20) | |
Q7. Which part of the eye is affected? | |||||||
Cornea | 11 (22) | 22 (17.1) | 6 (15) | 6 (15) | 33 (20.4) | 6 (60) | < 0.011 |
Lens | 12 (24) | 29 (22.6) | 2 (5) | 0 | 31 (19.2) | 5 (50) | |
Retina | 8 (16) | 34 (27.8) | 11 (27.5) | 22 (55) | 45 (27.9) | 3 (30) | |
Optic nerve | 29 (48) | 51 (41.7) | 36 (90) | 24 (60) | 113 (70.1) | 8 (80) | |
Others | 0 | 0 | 0 | 0 | 2 (1.2) | 0 | |
None | 2 (4) | 17 (13.9) | 2 (5) | 2 (5) | 2 (1.2) | 0 | |
Q8. If glaucoma is present in your family, can you develop it? | |||||||
Yes | 31 (62) | 39 (32) | 34 (85) | 25 (62.5) | 69 (42.8) | 6 (60) | < 0.011 |
No | 14 (28) | 28 (23) | 3 (7.5) | 3 (7.5) | 75 (46.5) | 3 (30) | |
Do not know | 5 (10) | 55 (44) | 3 (7.5) | 12 (30) | 17 (10.5) | 1 (10) | |
Q9.Vision loss in glaucoma. | |||||||
Reversible | 11 (22) | 18 (14.8) | 7 (17.5) | 6 (15) | 44 (27.3) | 3 (30) | < 0.011 |
Irreversible | 33 (66) | 58 (47.5) | 25 (62.5) | 30 (75) | 96 (59.6) | 6 (60) | |
Don’t know | 6 (12) | 46 (37.7) | 8 (20) | 4 (10) | 21 (13) | 1 (10) | |
Q10. Is a person with diabetes or hypertension at risk of glaucoma? | |||||||
Yes | 41 (82) | 71 (58.2) | 36 (90) | 31 (77.5) | 154 (95.6) | 8 (80) | < 0.011 |
No | 5 (10) | 4 (3.3) | 0 | 0 | 3 (1.8) | 1 (10) | |
Don’t know | 4 (8) | 47 (38.5) | 4 (10) | 9 (22.5) | 5 (3.1) | 1 (10) | |
Q11. Is glaucoma treatable? | |||||||
Yes | 39 (78) | 65 (53.3) | 37 (92.5) | 38 (95) | 149 (92.5) | 7 (70) | < 0.011 |
No | 7 (14) | 17 (13.9) | 1 (2.5) | 2 (5) | 8 (4.9) | 2 (20) | |
Do not know | 4 (8) | 37 (30.3) | 2 (5) | 0 | 4 (2.4) | 1 (10) | |
Q12. What treatments are available? | |||||||
Eyedrops | 28 (56) | 66 (53) | 30 (75) | 33 (82.5) | 107 (66.4) | 7 (70) | < 0.011 |
Tablets | 14 (26) | 13 (10.5) | 23 (57.5) | 11 (27.5) | 49 (30.3) | 3 (30) | |
Laser | 13 (26) | 33 (26.9) | 25 (62.5) | 12 (30) | 49 (30.3) | 4 (40) | |
Surgery | 36 (72) | 64 (51) | 32 (80) | 14 (35) | 140 (86.9) | 8 (80) | |
Device implant | 1 (2) | 5 (4) | 23 (57.5) | 0 | 20 (12.4) | 0 | |
Others | 2 (4) | 0 | 0 | 0 | 1 (0.6) | 0 | |
None | 2 (4) | 20 (16.4) | 2 (5) | 0 | 1 (0.6) | 1 (10) | |
Q13. Treatment is lifelong. | |||||||
Yes | 20 (40) | 31 (25.4) | 19 (47.5) | 13 (32.5) | 87 (54.0) | 7 (70) | < 0.011 |
No | 17 (34) | 22 (18) | 10 (25) | 17 (42.5) | 53 (32.9) | 2 (20) | |
Do not know | 13 (26) | 69 (54.9) | 11 (27.5) | 10 (25) | 21 (13.0) | 1 (10) | |
Q14. It can be treated by eye donation. | |||||||
Yes | 25 (50) | 27 (22.1) | 6 (15) | 11 (27.5) | 38 (23.6) | 6 (60) | < 0.011 |
No | 15 (30) | 34 (27.9) | 25 (62.5) | 21 (52.5) | 86 (53.4) | 1 (10) | |
Do not know | 10 (20) | 61 (47.5) | 9 (22.5) | 8 (20) | 37 (22.9) | 3 (30) | |
Q15. Purpose of treatment in glaucoma. | |||||||
Restore vision | 32 (64) | 39 (31.9) | 16 (40) | 22 (55) | 103 (63.9) | 4 (40) | < 0.011 |
Delay progression | 16 (32) | 46 (37.7) | 28 (70) | 19 (47.5) | 51 (31.6) | 6 (60) | |
Do not know | 2 (4) | 37 (30.1) | 3 (7.5) | 3 (7.5) | 7 (4.3) | 0 |
- Citation: Nayak B, Chakraborty K, Palanisamy S, Rathod RS, Parija S, Panda BB. Knowledge, attitudes, and practice patterns regarding glaucoma among medical students and healthcare professionals in Eastern India. World J Methodol 2025; 15(4): 105287
- URL: https://www.wjgnet.com/2222-0682/full/v15/i4/105287.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i4.105287